Genetic Analysis AS: Mandatory notification of trade
OSLO, NORWAY - 15 September 2021: Genetic Analysis AS (“GA” or “the Company”) announce that members of the Board and management have been allocated GEAN-shares and warrants of series TO 1 and TO 2 in connection with their IPO subscription.Kathryn M. Baker, Chairperson of the Board in Genetic Analysis AS, has through the fully owned company Lakeside AS today subscribed for and been allocated 64,100 GEAN-shares at a price of 7.80 NOK per share and in addition free of charge 38,460 subscription rights of series T0 1 and 44,870 subscription rights of series T0 2. Kathryn M. Baker including